Class action by businesses in the complementary medicines industry

We successfully defended a class action against five individual officers of the Therapeutic Goods Administration (TGA) worth in excess of $150 million. The class action was brought by 169 businesses in the complementary medicines industry who alleged substantial losses following the suspension by the TGA of the manufacturing licence of Pan Pharmaceuticals and subsequent recall of products. The litigation raised issues concerning the conduct of representative proceedings and involved a complex factual matrix which necessitated a labour intensive forensic factual investigation and assessment. A court-ordered mediation extending over four days resulted in a settlement of the action. The settlement was approved by the Federal Court of Australia. There was no finding nor concession of any wrongdoing by our clients. The compensation paid to the represented class of applicants was provided by the Commonwealth of Australia, which was the first respondent in the proceedings.


Related Articles

12 SENIOR MORAY & AGNEW LAWYERS RANKED IN ‘BEST LAWYERS IN AUSTRALIA’ LIST

Media Release

The 2017 list of ‘Best Lawyers in Australia’ was published online by the Australian Financial Review on 26 February 2016. Moray &…

Continue reading

Work Health and Safety Update

Legal Directions

DPP v CLM Infrastructure Pty Ltd [2017] VCC 192 (3 March 2017) The defendant, CLM Infrastructure Pty Ltd (‘CLM’), pleaded guilty…

Continue reading

Liable, but without a more probable than not cause

Legal Directions

Weber v Greater Hume Shire Council [2019] NSWCA 74 Background The defendant (respondent on the appeal), Greater Hume Shire Council (Council),…

Continue reading